Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)

Author： Mustea A.   Koensgen D.   Belau A.   Sehouli J.   Lichtenegger W.   Schneidewind L.   Sommer H.   Markmann S.   Scharf J.   Ehmke M.   Ledwon P.   Braicu I.   Zygmunt M.   Koehler G.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.5, 2013-11, pp. : 975-983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial

By Simon Thorsten   Längler Alfred   Harnischmacher Urs   Frühwald Michael   Jorch Norbert   Claviez Alexander   Berthold Frank   Hero Barbara  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 653-661

Springer Publishing Company

Access to resources Recommend Favorite

Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study

By Maluta S.   Dall'oglio S.   Romano M.   Marciai N.   Pioli F.   Giri M. G.   Benecchi P. L.   Comunale L.   Porcaro A. B.  

International Journal of Hyperthermia, Vol. 23, Iss. 5, 2007-01 ,pp. : 451-456

Informa Healthcare

Access to resources Recommend Favorite

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

By Gortzak E.   Azzarelli A.   Buesa J.   Bramwell V.H.C.   van Coevorden F.   van Geel A.N.   Ezzat  

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1096-1103

Elsevier

Access to resources Recommend Favorite

High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study

By                    

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 61-65

Spandidos Publications

Access to resources Recommend Favorite